Skip to content
Evigrade
MinorPlant alkaloid (isoquinoline), food supplement×Combined supplement: fat-soluble vitamins D3 and K2

Updated · Methodology

Mechanism

Berberine is a plant alkaloid. It is not authorised as a medicine in Spain and is sold as a food supplement, usually at 250–500 mg two or three times a day (LiverTox, NIH). In healthy men, berberine 300 mg three times a day for two weeks inhibited CYP2D6, CYP2C9 and CYP3A4: exposure to midazolam, a CYP3A4 substrate, rose by 40% (Guo et al., 2012). There is no medicinal product combining vitamins D3 and K2 in Spain, so the information on vitamin D3 comes from the colecalciferol SmPC. Colecalciferol is absorbed in the gut with the help of bile salts, better with food. It is converted in the liver and kidneys to active calcitriol and excreted mainly in bile and faeces (Colecalciferol Normon SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS, sections 4.2 and 5.2). Antiepileptics, barbiturates and possibly other liver enzyme inducers reduce its effect, as do glucocorticoids. Colestyramine, colestipol, orlistat and liquid paraffin reduce its absorption. Thiazide diuretics retain calcium, and with cardiac glycosides the risk of arrhythmia rises (Colecalciferol Normon SmPC, AEMPS, section 4.5). There is no medicinal product containing vitamin K2 (menaquinone-7). According to the NIH Office of Dietary Supplements vitamin K fact sheet, vitamin K interacts with warfarin and other anticoagulants, and antibiotics, bile acid sequestrants and orlistat can affect vitamin K levels. This combination has not been studied. Among the drugs that alter vitamin D3 action, the colecalciferol SmPC names liver enzyme inducers, whereas berberine inhibits these enzymes, and its effect on vitamin D3 is unknown (Colecalciferol Normon SmPC, AEMPS, section 4.5).

Symptoms

No symptoms caused by this combination have been described. Berberine's adverse effects are usually mild and transient: nausea, bloating, diarrhoea or constipation. In controlled trials they were no more frequent than with placebo, and no liver injury from berberine has been described (LiverTox, NIH). Excess vitamin D raises calcium in the blood and urine, causing nausea, vomiting, thirst, constipation, polyuria and dehydration. Chronic overdose can cause vascular and organ calcification (Colecalciferol Normon SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS, section 4.9). Vitamin K has low toxicity, and no tolerable upper intake level has been set (NIH Office of Dietary Supplements, vitamin K fact sheet).

Management

The combination can be used and no dose change is needed. There are no data on an interaction, and no mechanism that would cause one is known (Colecalciferol Normon SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS, section 4.5). When vitamin D3 is taken long term at more than 1000 IU a day, serum calcium is monitored. Colecalciferol is not used in hypercalcaemia, hypercalciuria, kidney stones or severe renal impairment (Colecalciferol Normon SmPC, AEMPS, sections 4.3 and 4.4). Because berberine inhibits CYP2D6, CYP2C9 and CYP3A4, bear in mind that it may raise the levels of other drugs metabolised by these enzymes (Guo et al., 2012).

Your whole list in one report

Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email

Add more drugs

Medicine list: everything you take in one place →

Sources

Other interactions with Berberine

Other interactions with Cholecalciferol + menaquinone-7 (D3+K2 combo)